BCX7353
BCX7353 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Long Term Safety Study of BCX7353 in Hereditary Angioedema
Study of BCX7353 as a Treatment for Attacks of Hereditary Angioedema
Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema
A Relative Bioavailability Study of Two Formulations of BCX7353
A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions
Clinical Trials (6)
A Long Term Safety Study of BCX7353 in Hereditary Angioedema
Study of BCX7353 as a Treatment for Attacks of Hereditary Angioedema
Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema
A Relative Bioavailability Study of Two Formulations of BCX7353
A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions
First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BCX7353 in Healthy Western and Japanese Volunteers
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6